These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
494 related articles for article (PubMed ID: 28412471)
1. Surface modification of solid lipid nanoparticles for oral delivery of curcumin: Improvement of bioavailability through enhanced cellular uptake, and lymphatic uptake. Baek JS; Cho CW Eur J Pharm Biopharm; 2017 Aug; 117():132-140. PubMed ID: 28412471 [TBL] [Abstract][Full Text] [Related]
2. Hansen solubility parameters (HSP) for prescreening formulation of solid lipid nanoparticles (SLN): in vitro testing of curcumin-loaded SLN in MCF-7 and BT-474 cell lines. Doktorovova S; Souto EB; Silva AM Pharm Dev Technol; 2018 Jan; 23(1):96-105. PubMed ID: 28949267 [TBL] [Abstract][Full Text] [Related]
3. Design and evaluation of polymer coated carvedilol loaded solid lipid nanoparticles to improve the oral bioavailability: a novel strategy to avoid intraduodenal administration. Venishetty VK; Chede R; Komuravelli R; Adepu L; Sistla R; Diwan PV Colloids Surf B Biointerfaces; 2012 Jun; 95():1-9. PubMed ID: 22463845 [TBL] [Abstract][Full Text] [Related]
4. Enhanced oral delivery of curcumin from N-trimethyl chitosan surface-modified solid lipid nanoparticles: pharmacokinetic and brain distribution evaluations. Ramalingam P; Ko YT Pharm Res; 2015 Feb; 32(2):389-402. PubMed ID: 25082210 [TBL] [Abstract][Full Text] [Related]
5. Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability. Sun J; Bi C; Chan HM; Sun S; Zhang Q; Zheng Y Colloids Surf B Biointerfaces; 2013 Nov; 111():367-75. PubMed ID: 23856543 [TBL] [Abstract][Full Text] [Related]
6. A combination of complexation and self-nanoemulsifying drug delivery system for enhancing oral bioavailability and anticancer efficacy of curcumin. Shukla M; Jaiswal S; Sharma A; Srivastava PK; Arya A; Dwivedi AK; Lal J Drug Dev Ind Pharm; 2017 May; 43(5):847-861. PubMed ID: 27648633 [TBL] [Abstract][Full Text] [Related]
7. Redox sensitive lipid-camptothecin conjugate encapsulated solid lipid nanoparticles for oral delivery. Du Y; Ling L; Ismail M; He W; Xia Q; Zhou W; Yao C; Li X Int J Pharm; 2018 Oct; 549(1-2):352-362. PubMed ID: 30099214 [TBL] [Abstract][Full Text] [Related]
8. Core-shell microcapsules of solid lipid nanoparticles and mesoporous silica for enhanced oral delivery of curcumin. Kim S; Diab R; Joubert O; Canilho N; Pasc A Colloids Surf B Biointerfaces; 2016 Apr; 140():161-168. PubMed ID: 26752213 [TBL] [Abstract][Full Text] [Related]
9. Solid lipid nanoparticles for oral drug delivery: chitosan coating improves stability, controlled delivery, mucoadhesion and cellular uptake. Luo Y; Teng Z; Li Y; Wang Q Carbohydr Polym; 2015 May; 122():221-9. PubMed ID: 25817662 [TBL] [Abstract][Full Text] [Related]
10. Development and in vivo evaluation of an innovative "Hydrochlorothiazide-in Cyclodextrins-in Solid Lipid Nanoparticles" formulation with sustained release and enhanced oral bioavailability for potential hypertension treatment in pediatrics. Cirri M; Mennini N; Maestrelli F; Mura P; Ghelardini C; Di Cesare Mannelli L Int J Pharm; 2017 Apr; 521(1-2):73-83. PubMed ID: 28229944 [TBL] [Abstract][Full Text] [Related]
11. Enhancing the oral bioavailability of curcumin using solid lipid nanoparticles. Ban C; Jo M; Park YH; Kim JH; Han JY; Lee KW; Kweon DH; Choi YJ Food Chem; 2020 Jan; 302():125328. PubMed ID: 31404868 [TBL] [Abstract][Full Text] [Related]
12. Recent developments in solid lipid nanoparticle and surface-modified solid lipid nanoparticle delivery systems for oral delivery of phyto-bioactive compounds in various chronic diseases. Ganesan P; Ramalingam P; Karthivashan G; Ko YT; Choi DK Int J Nanomedicine; 2018; 13():1569-1583. PubMed ID: 29588585 [TBL] [Abstract][Full Text] [Related]
13. Development of solid lipid nanoparticles as carriers for improving oral bioavailability of glibenclamide. Gonçalves LM; Maestrelli F; Di Cesare Mannelli L; Ghelardini C; Almeida AJ; Mura P Eur J Pharm Biopharm; 2016 May; 102():41-50. PubMed ID: 26925503 [TBL] [Abstract][Full Text] [Related]
14. Novel nanoemulsion based lipid nanosystems for favorable in vitro and in vivo characteristics of curcumin. Wan K; Sun L; Hu X; Yan Z; Zhang Y; Zhang X; Zhang J Int J Pharm; 2016 May; 504(1-2):80-8. PubMed ID: 27034002 [TBL] [Abstract][Full Text] [Related]
16. Improved oral delivery of resveratrol from N-trimethyl chitosan-g-palmitic acid surface-modified solid lipid nanoparticles. Ramalingam P; Ko YT Colloids Surf B Biointerfaces; 2016 Mar; 139():52-61. PubMed ID: 26700233 [TBL] [Abstract][Full Text] [Related]
17. Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles. Yuan H; Chen CY; Chai GH; Du YZ; Hu FQ Mol Pharm; 2013 May; 10(5):1865-73. PubMed ID: 23495754 [TBL] [Abstract][Full Text] [Related]
18. Enhancement of Curcumin Bioavailability by Encapsulation in Sophorolipid-Coated Nanoparticles: An in Vitro and in Vivo Study. Peng S; Li Z; Zou L; Liu W; Liu C; McClements DJ J Agric Food Chem; 2018 Feb; 66(6):1488-1497. PubMed ID: 29378117 [TBL] [Abstract][Full Text] [Related]
19. Solid Lipid Nanoparticles Approach for Lymphatic Targeting Through Intraduodenal Delivery of Quetiapine Fumarate. Yasir M; Gaur PK; Puri D; Shehkar P; Kumar SS Curr Drug Deliv; 2018; 15(6):818-828. PubMed ID: 28545354 [TBL] [Abstract][Full Text] [Related]
20. Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin. Ji H; Tang J; Li M; Ren J; Zheng N; Wu L Drug Deliv; 2016; 23(2):459-70. PubMed ID: 24892628 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]